Notice Regarding Organizational Restructuring of Group Companies

We hereby announce that our subsidiaries, CMIC Pharma Science Co., Ltd. (Head Office: Hokuto City, Yamanashi Prefecture; President & CEO: Takahiro Natsume; hereinafter “CMIC Pharma Science”) and Hamamatsu Pharma Research, Inc. (Head Office: Hamamatsu City, Shizuoka Prefecture; President: Takahiro Natsume; hereinafter “Hamamatsu Pharma Research”) will be integrated through an absorption-type merger, with CMIC Pharma Science as the surviving company and Hamamatsu Pharma Research as the dissolving company. https://en.cmicgroup.com/news-events/organizational-restructuring-of-cmic-group-companies/